How to diagnose axial spondyloarthritis early

Annals of the Rheumatic Diseases

Volumn 63, Issue 5, 2004, Pages 535-543

  Rudwaleit, M ^a,b   Van Der Heijde, D ^c   Khan, M A ^d   Braun, J ^e   Sieper, J ^b  

^a Medizinische Klinik I   (Germany)

^b Rheumatology   (Germany)

^c MAASTRICHT UNIVERSITY   (Netherlands)

^d METROHEALTH MEDICAL CENTER   (United States)

^e RHEUMAZENTRUM RUHRGEBIET   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HLA B27 ANTIGEN; NONSTEROID ANTIINFLAMMATORY AGENT;

ACUTE DISEASE; ACUTE PHASE RESPONSE; ALGORITHM; ANKYLOSING SPONDYLITIS; ARTHRITIS; ARTICLE; AXIAL SPONDYLOARTHRITIS; BACKACHE; BONE DISEASE; BUTTOCK; CHRONIC DISEASE; CLINICAL FEATURE; CONTROLLED STUDY; DRUG RESPONSE; EARLY DIAGNOSIS; ENTERITIS; ENTHESITIS; FAMILY HISTORY; HUMAN; IMAGE ANALYSIS; INFLAMMATORY DISEASE; IRIDOCYCLITIS; LABORATORY TEST; LOW BACK PAIN; MAJOR CLINICAL STUDY; PAIN; PARAMETER; PREVALENCE; PRIORITY JOURNAL; PROBABILITY; PSORIASIS; SENSITIVITY AND SPECIFICITY; SPONDYLOARTHROPATHY;

AXIS; CHRONIC DISEASE; DECISION TREES; EARLY DIAGNOSIS; HLA-B27 ANTIGEN; HUMANS; LOW BACK PAIN; SENSITIVITY AND SPECIFICITY; SPONDYLARTHRITIS;

EID: 1942436201     PISSN: 00034967     EISSN: None     Source Type: Journal    
DOI: 10.1136/ard.2003.011247     Document Type: Article

References (60)

1. Deyo RA, Weinstein JN. Low bock pain. N Engl J Med 2001;344:363-70.
2. Khan MA. Update on spondyloarthropothies. Ann Intern Med 2002;136:896-907.
3. Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, et al. Prevalence of spondylarthropothies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998;41:58-67.
4. Saraux A, Guedes C, Allain J, Devauchelle V, Valls I, Lamour A, et al. Prevalence of rheumatoid arthritis and spondyloarthropothy in Brittany, France. Societe de Rhumatologie de l'Ouest. J Rheumatol 1999;26:2622-7.
5. Gran JT, Husby G, Hordvik M. Prevalence of ankylosing spondylitis in males and females in a young middle-aged population in Tromso, northern Norway. Ann Rheum Dis 1985;44:359-67.
6. Braun J, Sieper J, Breban M, Collantes-Estevez E, Davis J, Inman R, et al. Anti-tumour necrosis factor α therapy for ankylosing spondylitis: international experience. Ann Rheum Dis 2002;61(suppl III):iii51-60.
7. Braun J, Brandt J, Listing J, Zink A, Alten R, Krause A, et al. Treatment of active ankylosing spandylitis with infliximab - a double-blind placebo controlled multicenter trial, Lancet 2002;359:1187-93.
8. Gorman JD, Sack KE, Davis JC. Treatment of ankylosing spondylitis by inhibition of tumor necrosis factor alpha. N Engl J Med 2002;346:1349-56.
9. Van den Bosch F, Kruithof E, Baeten D, Herssens A, de Keyser F, Mielants H, et al. Randomized double-blind comparison of chimeric monoclonal antibody to tumor necrosis factor alpha (infliximab) versus placebo in active spondylarthropathy. Arthritis Rheum 2002;46:755-65.
10. Van der Linden SM, Valkenburg HA, Cats A. Evaluation of the diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York criteria. Arthritis Rheum 1984;27:361-8.
11. Khan MA. Ankylosing spondylitis: introductory comments on its diagnosis and treatment. Ann Rheum Dis 2002;61(suppl III):iii3-7.
12. Mau W, Zeidler H, Mau R, Majewski A, Freyschmidt J, Stangel W, et al. Clinical features and prognosis of patients with possible ankylosing spondylitis. Results of a 10-year followup. J Rheumatol 1988;15:1109-14.
13. Feldtkeller E, Khan MA, van der Heijde D, van der Linden S, Braun J. Age at disease onset and diagnosis delay in HLA-B27 negative vs. positive patients with ankylosing spondylitis. Rheumatol Int 2003;23:61-6.
14. Dougados M, van der Linden S, Juhlin R, Huitfeldt B, Amor B, Calin A, et al. The European Spondylarthropathy Study Group preliminary criteria for the classification spondylarthropathy. Arthritis Rheum 1991;34:1218-27.
15. Amor B, Dougados M, Mijiyawa M. Critères de classification des spondylarthropathies. Rev Rhum 1990;57:85-9.
16. Amor B, Dougados M, Listrat V, Menkes G, Roux H, Benhamou C, et al. Are classification criteria for spondylarthropathy useful as diagnostic criteria? Rev Rhum Engl Ed 1995;62:10-15.
17. Mau W, Zeidler H, Mau R, Majewski A, Freyschmidt J, Stangel W, et al. Evaluation of early diagnostic criteria for ankylosing spondylitis in a 10 year follow-up. Z Rheumatol 1990;49:82-7.
18. Dougados M. Diagnostic features of ankylosing spondylitis. Br J Rheumatol 1995;34:301-5.
19. Collantes E, Veroz R, Escudero A, Munoz E, Munoz MC, Cisnal A, et al. Can some cases of 'possible' spondyloarthropathy be classified as 'definite' or 'undifferentiated' spondyloarthropathy? Value of criteria for spandyloarthropathies. Spanish Spondyloarthropathy Study Group. Joint Bone Spine 2000;67:516-20.
20. Amor B. Usefulness of criteria for spondyloarthropathies. Joint Bone Spine 2000;67:502-3.
21. Rudwaleit M, Metter A, Listing J, Sieper J, Braun J. Clinical parameters in the differentiation of inflammatory back pain from non-inflammatory back pain [abstract]. Ann Rheum Dis 2002;61(suppl I):57.
22. Calin A, Porta J, Fries JF, Schurmann DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA 1977;237:2613-14.
23. Goei The HS, Steven MM, van der Linden SM, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a comparison of the Rome, New York and modified New York criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheumatol 1985;24:242-9.
24. Van der Linden SM, Fahrer H. Occurrence of spinal pain syndromes in a group of apparently healthy and physically fit sportsmen (orienteers). Scand J Rheumatol 1988;17:475-81.
25. Gran JT. An epidemiological survey of the signs and symptoms of ankylosing spondylitis. Clin Rheumatol 1985;4:161-9.
26. Amor B, Dougados M, Listrat V, Menkes CJ, Dubost JJ, Roux H, et al. Évaluation des critères des spondylarthropathies d'Amor et de l'European Spondylarthropathy Study Group (ESSG). Ann Med Interne 1991;142:85-9.
27. Boyer GS, Templin DW, Goring WP. Evaluation of the European Spondylarthropathy Study Group preliminary classification criteria in Alaskan Eskimo populations. Arthritis Rheum 1993;36:534-8.
28. Collantes-Estevez E, Cisnal del Mazo A, Munoz-Gomariz E. Assessment of 2 systems of spondyloarthropathy diagnostic and classification criteria (Amor and ESSG) by a Spanish multicenter study. European Spondyloarthropathy Study Group. J Rheumatol 1995;22:246-51.
29. Hukuda S, Minami M, Saito T, Mitsu H, Matsui N, Komatsubara Y, et al. Spondyloarthropathies in Japan: nationwide qeustionnaire survey performed by the Japan Ankylosing Spondylitis Society. J Rheumatol 2001;28:554-9.
30. Cury SE, Vilar MJ, Ciconelli RM, Ferraz MB, Atra E. Evaluation of the European Spondylarthropathy Study Group (ESSG) preliminary classification criteria in Brazilian patients. Clin Exp Rheumatol 1997;15:79-82.
31. Baddoura R, Awada H, Okais J, Habis T, Affoui S, Abi Saab M. Validation of the European Spondylarthropathy Study Group and B. Amor criteria for spondylarthropothies in Lebanon. Rev Rhum Engl Ed 1997;64:459-64.
32. Calin A, Kaye B, Sternberg M, Antell B, Chan M. The prevalence and nature of back pain in an industrial complex. A questionnaire and radiographic and HLA analysis. Spine 1980;5:201-5.
33. Underwood MR, Dawes P. Inflammatory back pain in primary care. Br J Rheumatol 1995;34:1074-7.
34. Sadowska-Wráblewska M, Filipowicz A, Garwolinska H, Michalski J, Rusiniak B, Wróblewska T. Clinical signs and symptoms useful in the early diagnosis of ankylosing spondylitis. Clin Rheumatol 1983;2:37-43.
35. Dougados M, Gueguen A, Nakache J-P, Velicitat P, Zeidler H, Veys E, et al. Clinical relevance of C-reactive protein in axial involvement of ankylosing spondylitis. J Rheumatol 1999;26:971-4.
36. Spoorenberg A, van der Heijde D, de Klerk E, Dougados M, de Vlam K, Mielants H, et al. Relative value of erythrocyte sedimentation rate and C-reactive protein in assessment of disease activity in ankylosing spondylitis. J Rheumatol 1999;26:980-4.
37. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM. High association of an HL-A antigen, W27, with ankylosing spondylitis. N Engl J Med 1973;288:704-6.
38. Brewerton DA, Hart FD, Nicholls A, Caffrey M, James DC, Sturrock RD. Ankylosing spondylitis and HL-A 27. The Lancet 1973;i:904-7.
39. Brophy S, Calin A. Ankylosing spondylitis: interaction between genes, joints, age at onset, and disease expression. J Rheumatol 2001;28:2283-8.
40. Braun J, Bollow M, Eggens U, Konig H, Distler A, Sieper J. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum 1994;37:1039-45.
41. Hanly JG, Mitchell MJ, Barnes DC, MacMillan L. Early recognition of sacroiliitis by magnetic resonance imaging and single photon emission computed tomography. J Rheumatol 1994;21:2088-95.
42. Bollow M, Braun J, Hamm B, Eggens U, Schilling A, Konig H, et al. Early sacroiliitis in patients with spondyloarthropothy: evaluation with dynamic gadolinium-enhanced MR imaging. Radiology 1995;194:529-36.
43. Blum U, Buitrago-Tellez C, Mundinger A, Krause T, Laubenberger J, Vaith P, et al. Magnetic resonance imaging (MRI) for detection of active sacroiliitis - a prospective study comparing conventional radiography, scintigraphy, and contrast enhanced MRI. J Rheumatol 1996;23:2107-15.
44. Puhakka KB, Jurik AG, Egund N, Schiottz-Christensen B, Stengaard-Pedersen K, van Overeem Hansen G, et al. Imaging of sacroiliitis in early seronegative spondylarthropathy. Assessment of abnormalities by MR in comparison with radiography and CT. Acta Radiol 2003;44:218-29.
45. Miron SD, Khan MA, Wiesen EJ, Kushner I, Bellon EM. The value of quantitative sacroiliac scintigraphy in detection of sacroiliitis. Clin Rheumatol 1983;2:407-14.
46. Goei The HS, Lemmens AJ, Goedhard G, Lokkerbol H, Rahmy A, Steven MM, et al. Radiological and scintigraphic findings in patients with a clinical history of chronic inflammatory back pain. Skeletal Radiol 1985;14:243-8.
47. Griner PF, Mayewski RJ, Mushlin AI, Greenland P. Selection and interpretation of diagnostic tests and procedures: principles and applications. Ann Intern Med 1981;94:553-600.
48. Pauker SG, Kassirer JP. Decision analysis. N Engl J Med 1987;316:250-8.
49. Sackett DL, Haynes RB, Guyatt GH, Tugwell P. Clinical epidemiology: a basic science for clinical medicine. 2nd ed. Boston, Toronto, London: Little, Brown, 1991:69-152.
50. Brandt J, Bollow M, Haberle J, Rudwaleit M, Eggens U, Distler A, et al. Studying patients with inflammatory back pain and arthritis of the lower limbs clinically and by magnetic resonance imaging: many, but not all patients with sacroiliitis have spondyloarthropathy. Rheumatology (oxford) 1999;38:831-6.
51. Sieper J, Rudwaleit M, Braun J, van der Heijde D. Diagnosing reactive arthritis. Role of clinical setting in the value of serologic and microbiologic assays. Arthritis Rheum 2002;46:319-27.
52. Khan MA. Clinical application of HLA-B27 test in rheumatic diseases: a current perspective. Arch Intern Med 1980;140:177-80.
53. Hawkins BR, Dawkins RL, Christiansen FT, Zilko PJ. Use of the B27 test in the diagnosis of ankylosing spondylitis: a statistical evaluation. Arthritis Rheum 1981;24:743-6.
54. Khan MA, Khan MK. Diagnostic value of HLA-B27 testing ankylosing spondylitis and Reiter's syndrome. Ann Intern Med 1982;96:70-6.
55. Baron M, Zendel I. HLA-B27 testing in ankylosing spondylitis: an analysis of the pretesting assumptions. J Rheumatol 1989;16:631-4.
56. Gran JT, Husby G. HLA-B27 and spondyloarthropathy: value for early diagnosis? J Med Genet 1995;32:497-501.
57. Khan MA. HLA-B27 polymorphism and association with disease. J Rheumatol 2000;27:1110-14.
58. Gran JT, Nordvag BY. Referrals from general practice to an outpatient rheumatology clinic: disease spectrum and analysis of referral letters. Clin Rheumatol 2000;19:450.
59. Fries JF, Hochberg MC, Medsger TA, Hunder GG, Bambardier C. Criteria for rheumatic disease. Different types and different functions. The Amercian College of Rheumatology diagnostic and therapeutic criteria committee. Arthritis Rheum 1994;37:454-62.
60. Hunder GG. The use and misuse of classification and diagnostic criteria for complex diseases. Ann Intern Med 1998;129:417-18.